Literature DB >> 18722615

Collagen type 3 alpha 1 polymorphism and risk of pelvic organ prolapse.

Huey-Yi Chen1, Ya-Wen Chung, Wei-Yong Lin, Jiunn-Chin Wang, Fuu-Jen Tsai, Chang-Hai Tsai.   

Abstract

OBJECTIVE: To investigate whether pelvic organ prolapse (POP) is associated with collagen 3 alpha 1 (COL3A1) polymorphisms and other factors.
METHODS: A case-control association study was conducted with 84 women affected with POP and 147 controls. The genotypes of nucleotides COL3A1 rs1800255 and COL3A1 rs1801184 polymorphisms were ascertained by polymerase chain reaction and restriction fragment length polymorphism analysis.
RESULTS: The distribution of the COL3A1 rs1800255 genotypes was significantly different among affected women and controls. Older age and incidence of COL3A1 rs1800255 genotype AA were significantly associated with risk of POP.
CONCLUSION: There may be an association between COL3A1 genotype and risk of POP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18722615     DOI: 10.1016/j.ijgo.2008.05.031

Source DB:  PubMed          Journal:  Int J Gynaecol Obstet        ISSN: 0020-7292            Impact factor:   3.561


  21 in total

1.  Collagen type III alpha 1 polymorphism (rs1800255, COL3A1 2209 G>A) assessed with high-resolution melting analysis is not associated with pelvic organ prolapse in the Dutch population.

Authors:  Sabrina L Lince; Leon C van Kempen; Jeroen R Dijkstra; Joanna IntHout; Mark E Vierhout; Kirsten B Kluivers
Journal:  Int Urogynecol J       Date:  2014-04-24       Impact factor: 2.894

2.  Polymorphism rs1800255 from COL3A1 gene and the risk for pelvic organ prolapse.

Authors:  Fernando Henrique Teixeira; César Eduardo Fernandes; Ricardo Peres do Souto; Emerson de Oliveira
Journal:  Int Urogynecol J       Date:  2019-04-30       Impact factor: 2.894

3.  Comprehensive analysis of LAMC1 genetic variants in advanced pelvic organ prolapse.

Authors:  Jennifer M Wu; Anthony G Visco; Elizabeth A Grass; Damian M Craig; Rebekah G Fulton; Carol Haynes; Cindy L Amundsen; Svati H Shah
Journal:  Am J Obstet Gynecol       Date:  2012-01-31       Impact factor: 8.661

4.  Identification of pelvic organ prolapse risk susceptibility gene SNP locus in Xinjiang women.

Authors:  Aibibuhan Abulaizi; Abudoureyimu Abula; Gulina Ababaikeli; Xiaohui Wan; Rong Du; Adilai Zhakeer
Journal:  Int Urogynecol J       Date:  2019-07-02       Impact factor: 2.894

Review 5.  Genetics of pelvic organ prolapse: crossing the bridge between bench and bedside in urogynecologic research.

Authors:  Maria Augusta Tezelli Bortolini; Diaa E E Rizk
Journal:  Int Urogynecol J       Date:  2011-07-26       Impact factor: 2.894

6.  COL3A1 2209G>A is a predictor of pelvic organ prolapse.

Authors:  Kirsten B Kluivers; Jeroen R Dijkstra; Jan C M Hendriks; Sabrina L Lince; Mark E Vierhout; Léon C L van Kempen
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2009-05-15

7.  Matrix metalloproteinase-9 genetic polymorphisms and the risk for advanced pelvic organ prolapse.

Authors:  Jennifer M Wu; Anthony G Visco; Elizabeth A Grass; Damian M Craig; Rebekah G Fulton; Carol Haynes; Alison C Weidner; Svati H Shah
Journal:  Obstet Gynecol       Date:  2012-09       Impact factor: 7.661

8.  Characterizing the phenotype of advanced pelvic organ prolapse.

Authors:  Pamela J Levin; Anthony G Visco; Svati H Shah; Rebekah G Fulton; Jennifer M Wu
Journal:  Female Pelvic Med Reconstr Surg       Date:  2012 Sep-Oct       Impact factor: 2.091

Review 9.  Genetic epidemiology of pelvic organ prolapse: a systematic review.

Authors:  Renée M Ward; Digna R Velez Edwards; Todd Edwards; Ayush Giri; Rebecca N Jerome; Jennifer M Wu
Journal:  Am J Obstet Gynecol       Date:  2014-04-12       Impact factor: 8.661

10.  Highly purified collagen coating enhances tissue adherence and integration properties of monofilament polypropylene meshes.

Authors:  Rodrigo Teixeira Siniscalchi; Marli Melo; Paulo César Rodrigues Palma; Inácio Maria Dal Fabbro; Benedicto de Campos Vidal; Cassio Luiz Zanettini Riccetto
Journal:  Int Urogynecol J       Date:  2013-05-04       Impact factor: 2.894

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.